The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
about
GPER Function in Breast Cancer: An OverviewFunction of G-Protein-Coupled Estrogen Receptor-1 in Reproductive System TumorsThe G-protein-coupled estrogen receptor GPER in health and diseaseThe role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cellsG-protein oestrogen receptor 1: trials and tribulations of a membrane oestrogen receptorDouble-edged role of G protein-coupled estrogen receptor 1 in breast cancer prognosis: an analysis of 167 breast cancer samples and online data setsEpigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancerGPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breastProteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells.GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice.Estrogens of multiple classes and their role in mental health disease mechanisms.Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancerN-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth.Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potentialA common hypofunctional genetic variant of GPER is associated with increased blood pressure in women.GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signalsThe G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.Estrogenic and anti-estrogenic activity of off-the-shelf hair and skin care productsEstrogen action and prostate cancer.G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signallingUnraveling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways.The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1.G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium.International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic ModulatorsEstrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.Gestational bisphenol A exposure and testis development.Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcomeG protein-coupled estrogen receptor-mediated effects on cytosolic calcium and nanomechanics in brain microvascular endothelial cells.Mechanisms of G protein-coupled estrogen receptor-mediated spinal nociception.The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivoG-1 Inhibits Breast Cancer Cell Growth via Targeting Colchicine-Binding Site of Tubulin to Interfere with Microtubule Assembly.GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivoOxidative/antioxidative enzyme-mediated antiproliferative and proapoptotic effects of the GPER1 agonist G-1 on lung cancer cells.GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells.Differences in GPR30 Regulation by Chlorotriazine Herbicides in Human Breast CellsRecent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling.Morphologic effects of estrogen stimulation on 3D MCF-7 microtissuesSynergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1.The G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Nuclear Estrogen Receptor Activity and Stimulates Novel Phosphoproteomic Signatures
P2860
Q21131274-AF1D71C3-CE23-4A5C-8275-9FE748C69CA0Q26744530-34C090F1-F127-400E-8C7E-E967AC8595E1Q27013052-2AFAD6CC-B433-4AD4-94DE-CF2E0D552B2DQ28390036-F61D034F-6589-4911-A421-B63E7CD286E4Q28567192-D4DF7694-98E3-404B-B129-ABD94CDFFBCFQ28576185-EEE2F63C-61DE-4ECA-B97C-E8CE20440029Q31141334-9FF79581-0685-478F-9C79-C927DC26CEDFQ33640340-858D7B08-F702-4D4D-A579-2EFCA641011EQ33882180-298907A9-4113-490D-A3F0-32B4ACF94B9AQ33954542-0237C425-1A3E-45FE-AF1D-F8511297A52CQ34132870-F8091702-3579-4B06-B1A2-EEC8272FF0E3Q34272184-91340128-D5AD-43E9-AED1-9F97480A95C2Q34526893-20B7ACB1-30B8-4CEC-A066-D7E91BEE7FB1Q34534676-74296486-F754-4898-8286-DAE91EF76165Q34571624-A2B34CE7-A843-4404-A6FF-D08DDB4499DCQ34635603-424FFDB4-A698-4A48-B634-70E2B93BCA42Q34696884-F9C908D1-65DF-4525-BB51-8AB9EF74D539Q34950615-EC33ADE6-1F2E-4020-8C54-38F69BB3F1B6Q35054696-1006B894-E9EC-47C3-8D39-FF232553C467Q35099011-7F8F0D02-8463-43A4-AEFD-25BD80C4B8FFQ35130507-B21A171C-15FB-4135-A4C7-F5912248DA34Q35130517-84BCE60C-0884-4A3F-8D60-39B3A05FE305Q35275278-7925BCC6-612D-47A1-8B44-DBF9FF5D5F2CQ35543259-D858CEE7-891E-4BD3-8107-0092700B482AQ35795751-DF62D6DD-13B8-405E-90F0-277132FDD3D1Q35809173-F2D674D7-0C03-4BC2-9240-C1F73FEC5C57Q35831711-5C02880B-E7E3-4A2A-B531-B9D761D9AE39Q35949565-87A86B26-BF60-4D97-A870-C62A8F2DDA2BQ36036783-E8D7118A-7450-40DE-8527-FACE056D4299Q36140716-001D74BC-8158-4433-BAA7-DE1D4198FB4DQ36291117-68CAF0DE-B77E-4F94-B2E9-954BF844DC96Q36297086-F3153D4C-5BA4-4253-955D-9F2F59EE89FDQ36326358-A49FA843-0C43-41CB-BA6D-20DA006D15A3Q36334424-BF98A246-5044-412E-B5F7-3E1C6AB957E9Q36547331-2CAE1A43-34AF-4F8D-8D90-1E2BB2FBAF85Q36587317-C68B2355-6868-434E-AE42-46D0EBE7EF95Q36653897-0ABB4696-C1DB-4F79-8F5D-61EFCD364AB2Q36715691-F04DEA88-9CB0-489D-AEB7-A35E256F8346Q36918232-0E8C998B-AEE8-4778-A9E4-688F4CE2CC28Q36935460-B789F5D4-62FC-4C25-B43E-EAFF1B94C02D
P2860
The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The G protein-coupled receptor ...... -positive breast cancer cells.
@ast
The G protein-coupled receptor ...... -positive breast cancer cells.
@en
type
label
The G protein-coupled receptor ...... -positive breast cancer cells.
@ast
The G protein-coupled receptor ...... -positive breast cancer cells.
@en
prefLabel
The G protein-coupled receptor ...... -positive breast cancer cells.
@ast
The G protein-coupled receptor ...... -positive breast cancer cells.
@en
P2093
P2860
P50
P1433
P1476
The G protein-coupled receptor ...... r-positive breast cancer cells
@en
P2093
Anne L Donato
Eric A Ariazi
Eugen Brailoiu
Heather A Shupp
Heather E Cunliffe
Jeffrey B Arterburn
Michael J Slifker
Smitha Yerrum
V Craig Jordan
P2860
P304
P356
10.1158/0008-5472.CAN-09-3068
P407
P577
2010-01-19T00:00:00Z